DOC News Track the topics, authors and articles important to you
HOME HELP SUBSCRIBE ARCHIVE SEARCH TABLE OF CONTENTS
FEEDBACK EDITORIAL BOARD ABOUT DOC NEWS
 QUICK SEARCH:   [advanced]


     


DOC News    November 1, 2007
Volume 4 Number 11 p. 15
© 2007 American Diabetes Association

Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cinnamon Offers No Benefit in Diabetes

To investigate whether powdered Cinnamomum cassia may be beneficial in type 2 diabetes—as some past research, mostly in animals, but some in humans, has indicated—a group of investigators conducted a controlled clinical trial of cinnamon consumption.


Figure 1
BANANASTOCK/JUPITER IMAGES

The researchers, from University of Oklahoma in Norman, Oklahoma City Department of Veterans Affairs Medical Center, and Oklahoma Medical Research Foundation, recruited 57 participants with type 2 diabetes for their study. Twenty-nine participants consumed a 500-mg capsule containing cinnamon twice daily for 3 months, while the remainder consumed a capsule containing wheat flour acting as a placebo.

The investigators tested participants' fasting glucose, cholesterol, triglyceride, and insulin levels at 1, 2, and 3 months after the initiation of cinnamon supplements. The participants showed high adherence with the protocol, based on regular capsule counts. The analyses revealed no differences between the two groups on any of the indicators.

Further research may identify whether cinnamon works for some people or in specific cases, the researchers note. "Until then," they conclude, "cinnamon cannot be generally recommended for treatment of type 2 diabetes in an American population."

Blevins SM, Leyva MJ, Brown J, et al.: Effect of cinnamon on glucose and lipid levels in non-insulin-dependent type 2 diabetes. Diabetes Care 30:2236–2237, 2007.[Free Full Text]


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP SUBSCRIBE ARCHIVE SEARCH TABLE OF CONTENTS
FEEDBACK EDITORIAL BOARD ABOUT DOC NEWS
DOC News Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum